期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

冠心病患者的血压控制策略以及钙拮抗剂的作用 被引量：2

Strategy of Controlling Blood Pressure in Cases of Coronary Heart Disease and Effects of Calcium Antagonists
下载PDF
导出
摘要 血压在冠心病发生、发展过程中起了及其重要的作用。近年多种大型临床试验的结果使以往冠心病患者血压控制策略、用药原则得到更新,并进一步强调了钙拮抗剂在冠心病血压控制中的作用。现对此进行综述,为正确选择药物,有效降低冠心病患者血压,减少临床事件提供理论依据。 Blood pressure has an important role in the formation and development of coronary heart disease. Recently, many clinical experiments have renewed the idea of blood pressure control via pharmaceuticals containing calcium antagonists in patients of coronary heart disease. The article reviews the renewed strategy, and ideas behind pharmaceutical choices.
作者 谢瑞芹 崔炜
机构地区 河北医科大学第二医院河北省心脑血管病研究所心内科
出处 《心血管病学进展》 CAS 2008年第4期545-549,共5页 Advances in Cardiovascular Diseases
关键词 冠心病 血压控制 钙拮抗剂 策略 coronary heart disease blood pressure control calcium antagonists
分类号 R541.4 [医药卫生—心血管疾病] R972 [医药卫生—药品]
  • 相关文献

参考文献18

  • 1Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention[ J]. Circulation, 2007,115 : 2761-2788.
  • 2Mancia G, de Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension :The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [ J]. Eur Heart J ,2007,28 : 1462-1536.
  • 3Lewington S, Clarke R ,Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality : a meta-analysis of individual data for one million adults in 61 prospective studies[J]. Lancet,2002 ,360 :1903-1913.
  • 4Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary, artery, disease:randomised, double-blind, placebo-controlled, muhicentre trial ( the EUROPA study) [ J ]. Lancet. 2003,362 : 782- 788.
  • 5Nissen SE ,Tuzcu EM ,Libby P,et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure:the CAMELOT study : a randomized controlled trial [ J ]. JAMA, 2004, 292 : 2217- 2225.
  • 6Julius S,Kjeldsen SE,Weber M,et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine : the VALUE randomised trial [ J ]. Lancet,2004,363:2022 -2031.
  • 7Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The Antlhypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [ J]. JAMA ,2002,288:2981-2997.
  • 8Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study:Intervention as a Goal in Hypertension Treatment (INSIGHT) [J]. Lancet,2000,356:366-372.
  • 9Zanchetti A, Hansson L, Clement D, et al. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles:does a J-shaped curve exist in smokers [ J ] ? J Hypertens ,2003,21 : 797 -804.
  • 10Hasebe N, Kikuchi K. Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi ( Nifedipine and Candesartan Combination) Study [ J ]. J Hypertens,2005,23 : 445-453.

同被引文献10

引证文献2

二级引证文献8

心血管病学进展
2008年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部